BioCentury
ARTICLE | Company News

MDCO seeking expanded Angiomax label

August 4, 2003 7:00 AM UTC

The Medicines Co. (MDCO) submitted an MAA and an sNDA to the EMEA and FDA, respectively, to expand the label for its Angiomax bivalirudin to treat patients undergoing percutaneous coronary interventio...